Navigation Links
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
Date:5/13/2008

1,582,027 2,420,837

Accrued compensation 715,036 941,300

Deferred revenue, current portion 1,916,669 4,864,833

Total current liabilities 5,474,714 9,564,705

Capital lease obligations and notes

payable, net of current portion 180,371 275,126

Deferred rent, net of current portion 1,597,647 1,966,628

Deferred revenue, net of current portion 6,388,886 12,443,087

Total liabilities 13,641,618 24,249,546

Stockholders' equity:

Preferred stock of $.01 par value -

authorized 10,000,000 shares;

Series A Convertible; issued and

outstanding 4,997 shares as of

December 31, 2007 and June 30, 2007 50 50

Common stock of $.01 par value -

authorized 150,000,000 shares; issued

and outstanding 85,204,169 and

85,126,915 shares as of December 31,

2007 and June 30, 2007, respectively 852,042 851,269

Additional paid-in capital 207,648,737 205,875,438

Accumulated other comprehensive income 62,098 -

Accumulated deficit (197,337,143) (188,195,069)

Total stockholders' equity 11,225,784 18,531,688

Total liabilities and stockholders'

equity $24,867,402 $42,781,234


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
2. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
3. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
4. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
5. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
8. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
9. Veran Medical Technologies Secures $4.75M in First Institutional Funding
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. InSet Technologies Appoints Jon Tremmel to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email: